Higher Doses of Botulinum Toxin in the Treatment of Gummy Smile
Summary
Botulinum type A (BTX-A) is an easy and efficacious treatment for gingival smile (GS). However, the necessary for higher-doses among patients are controversial. The objective was to compare the reduction of gingival exposure using two methods in patients with different dosage. In this prospective self-controlled study, healthy GS participates who had an anterior gingival exposure (GE) of more than 3 mm were enrolled and administered with 2-5 U BTX-A (total, 4-10 U) injections into 1-2 points according to the severity presented pretreatment in the Average-dose Method. And after 8 months, the Higher-doses Method was administered the same point injection of 3-10 U BTX-A (total, 6-20 U). Data were collected at baseline and 4, 12, 32 and 60 weeks of follow-up.
Timeline
- Start
- 2019-11-20
- Primary completion
- 2020-08-20
- Completion
- 2021-10-20
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Botulinum toxin type A | Protein / enzyme biologic | 2 iu | — |
| Subject | Botulinum toxin type A | Protein / enzyme biologic | 3 iu | — |
| Subject | Botulinum toxin type A | Protein / enzyme biologic | 5 iu | — |
| Subject | Botulinum toxin type A | Protein / enzyme biologic | 10 iu | — |
Indications
No indication recorded.